Delivery Order SPE2DB20D1100-SPE2DB25FE1A3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg on July 25, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be performed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $8,590.58 with a firm fixed price contract type. The award is non-set-aside and represents a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract specifies performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ofev 150 mg capsules (60-unit packages) with a ceiling value of $8,590.58. This firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a contract ceiling value of $8,590.58. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units). This firm fixed-price contract, awarded on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a non-competitive, open-market procurement. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of OFEV 150 mg capsules (60-count units) valued at $8,590.58 with a completion date of October 10, 2025. This is a firm fixed-price, non-set-aside contract delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $17,181.16 to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1A3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, classified as a competitive award. The contract is set to be completed by September 8, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency and other government healthcare programs worldwide. This specific delivery order for Ofev (pirfenidone), a specialty pharmaceutical used in the treatment of idiopathic pulmonary fibrosis, reflects the company's ongoing role in fulfilling federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 8/15/25 |